Jan 29, 2015
FDA Grants QIDP Designation to Neutrolin®, CorMedix Inc.’s Lead Product Candidate in the U.S.
Jan 15, 2015
CorMedix Inc. Receives Fast Track Designation For Neutrolin®
Dec 4, 2014
CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®
Dec 3, 2014
Neutrolin Label Expansion Approved in Germany
Oct 24, 2014
CorMedix Receives Approval from FDA to Initiate a Clinical Trial for Neutrolin in the US
Sep 25, 2014
CorMedix Announces FDA IND Filing for Neutrolin® in United States
Sep 19, 2014
Neutrolin Label Expansion Approved for the European Union
Aug 14, 2014
FDA Accepts CorMedix, Inc. Pivotal Phase 3 Study Protocol
Jun 23, 2014
CorMedix, Inc. Finalizes Pivotal Phase 3 Study Protocol for FDA
Jan 10, 2014
CorMedix Awarded European Patent for Neutrolin
Jan 8, 2014
CorMedix Inc. to Raise $2,000,000 in Follow on Offering
